ClinicalTrials.gov
ClinicalTrials.gov Menu

Transtheoretical Model of Behavior Change and Anxiety

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03363737
Recruitment Status : Completed
First Posted : December 6, 2017
Last Update Posted : December 7, 2017
Sponsor:
Information provided by (Responsible Party):
Paul D. Loprinzi, University of Mississippi, Oxford

Brief Summary:
Examine the utility of the Transtheoretical Model in influencing anxiety among college students. Employ a randomized controlled intervention including a static and dynamic Facebook intervention. The static group accessed a Facebook page featuring 96 statuses. Statuses were intended to engage cognitive processes, followed by behavioral processes of change per the Transtheoretical Model of behavior change. Content posted on the static Facebook page was identical to the dynamic page. However, the static group viewed all 96 statuses on the first day of the study, while the dynamic group received only 1-2 of these status updates per day throughout the intervention. Anxiety was measured using the Overall Anxiety Severity and Impairment Scale (OASIS). Time spent engaging in physical activity was assessed using the International Physical Activity Questionnaire (IPAQ).

Condition or disease Intervention/treatment Phase
Psychological Physical Activity Behavioral: Transtheoretical Model Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 39 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Can Facebook Reduce Perceived Anxiety Among College Students? A Randomized Controlled Exercise Trial Using the Transtheoretical Model of Behavior Change
Actual Study Start Date : October 18, 2016
Actual Primary Completion Date : August 24, 2017
Actual Study Completion Date : August 24, 2017

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Static Behavioral: Transtheoretical Model
Exposure to content on Facebook, either daily (dynamic) or just at one time period (static).

Experimental: Dynamic Behavioral: Transtheoretical Model
Exposure to content on Facebook, either daily (dynamic) or just at one time period (static).




Primary Outcome Measures :
  1. Changes in Anxiety [ Time Frame: At baseline and at the end of the 8-week intervention ]
    OASIS, Overall Anxiety Severity and Impairment Scale. There are 5 questions in this scale, with each question including 5 response options (ranging from 0-4). The total score is reported, which ranges from 0-20 (higher score indicates greater anxiety).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Having an active Facebook account
  • Daily access to a Smart Phone
  • Current University of Mississippi email account

Exclusion Criteria:

  • Outside the age range of 18-35

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Paul D. Loprinzi, Associate Professor of Health and Exercise Science, University of Mississippi, Oxford
ClinicalTrials.gov Identifier: NCT03363737     History of Changes
Other Study ID Numbers: 17-018
First Posted: December 6, 2017    Key Record Dates
Last Update Posted: December 7, 2017
Last Verified: December 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No